Charles River Laboratories | CRL - Interest Income



Charles River Laboratories reported $1.1M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Agilent USD 16M 2M Jul/2025
Align Technology USD 5.32M 3.21M Mar/2025
Bio-Rad Laboratories USD 14.7M 21.5M Jun/2025
Bruker 2.9M 200K Jun/2025
Charles River Laboratories USD 1.1M 307K Jun/2025
Danaher USD 8M 2M Jun/2025
Dentsply International 4M 1000K Mar/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Hologic USD 16.4M 1.5M Jun/2025
Illumina USD 10M 1000K Jun/2025
Incyte 25.14M 2.21M Jun/2025
IQVIA Holdings USD 10M 1000K Jun/2025
Merck 17M 11M Jun/2025
Pfizer USD 156M 13M Jun/2025
Quest Diagnostics USD 2M 3M Jun/2025
Revvity USD 10.08M 253K Mar/2025
Thermo Fisher Scientific USD 203M 24M Mar/2025
United Therapeutics USD 51.3M 200K Jun/2025
Waters USD 4.51M 618K Jun/2025
West Pharmaceutical Services USD 4.1M 700K Mar/2025